Clinical trial

Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)

NCT00157924

Study summary

ClinicalTrials.gov

Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention simvastatin (+) ezetimibe Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record atorvastatin Normalized identity: atorvastatin View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-11-01

PhasePHASE4

Conditions

Hypercholesterolemiaunresolved

Interventions

simvastatin (+) ezetimibeDRUG

atorvastatinDRUG · verified · RxNorm: atorvastatin

Sponsors & collaborators

Organon and Colead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00157924 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.